Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether blocking the mineralocorticoid receptor, alone, or in
combination with the calcimimetic cinacalcet, can lower parathyroid hormone and calcium
levels in primary hyperparathyroidism.